Take­da wins long-await­ed US ap­proval for first oral drug for eosinophilic esophagi­tis

The FDA on Mon­day ap­proved Take­da’s Eo­hil­ia, the first oral drug for pa­tients with eosinophilic esophagi­tis (EoE) in the US, which the com­pa­ny briefly aban­doned …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.